UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031457
Receipt number R000035875
Scientific Title Preventive effect of postoperative nausea and vomiting will be correlated with the dose of intraoperative acetaminophen : a randomized clinical trial about patients without pain
Date of disclosure of the study information 2018/02/24
Last modified on 2023/08/30 11:55:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preventive effect of postoperative nausea and vomiting will be correlated with the dose of intraoperative acetaminophen : a randomized clinical trial about patients without pain

Acronym

Preventive effect of postoperative nausea and vomiting will be correlated with the dose of intraoperative acetaminophen : a randomized clinical trial about patients without pain

Scientific Title

Preventive effect of postoperative nausea and vomiting will be correlated with the dose of intraoperative acetaminophen : a randomized clinical trial about patients without pain

Scientific Title:Acronym

Preventive effect of postoperative nausea and vomiting will be correlated with the dose of intraoperative acetaminophen : a randomized clinical trial about patients without pain

Region

Japan


Condition

Condition

Orthopedic upper limb or leg disorders

Classification by specialty

Orthopedics Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to verify the dose of intraoperative acetaminophen preventive effect of postoperative nausea and vomiting.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative nausea and vomiting evaluation performed by numerical rating scale(NRS) after 30 minutes,2 hours,6 hours,24 hours postoperatively.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

intraoperative intravenous acetaminophen 15mg/kg

Interventions/Control_2

intraoperative intravenous acetaminophen 7.5mg/kg

Interventions/Control_3

intraoperative intravenous saline 100ml

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients of ASA 1-2 who are scheduled to undergo general-epidural anesthesia or general-conduction anesthesia in an operation of orthopedic upper limb or leg

Key exclusion criteria

patients with liver or kidney disfunction or dementia

Target sample size

180


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sakurako Ichinokawa

Organization

National hospital organization Saitama hospital

Division name

Department of anesthesiology

Zip code


Address

2-1 Suwa, Wako-shi, Saitama

TEL

090-5437-0602

Email

sakux3tto@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Sakurako Ichinokawa

Organization

National hospital organization Saitama hospital

Division name

Department of anesthesiology

Zip code


Address

2-1 Suwa, Wako-shi, Saitama

TEL

090-5437-0602

Homepage URL


Email

sakux3tto@gmail.com


Sponsor or person

Institute

Department of anesthesiology,National hospital organization Saitama hospital

Institute

Department

Personal name



Funding Source

Organization

Department of anesthesiology,National hospital organization Saitama hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 24 Day

Date of IRB

2018 Year 02 Month 14 Day

Anticipated trial start date

2018 Year 02 Month 24 Day

Last follow-up date

2019 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 24 Day

Last modified on

2023 Year 08 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035875


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name